The Gores Group has made a binding offer to acquire Therakos from Ortho-Clinical Diagnostics. Therakos offers a therapy designed to reduce the skin symptoms associated with cutaneous T-cell lymphoma. Michael Rechtiene, who led the Therakos business between 2003 and 2006, will join Therakos as CEO upon the closing of the transaction.
